Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

PH-10 plus green light shows promise in pilot psoriasis study

April 26, 2001

Modex Therapeutics progresses in phase II clinical evaluation of EpiDex

April 25, 2001

Positive results obtained for HCT-1026 as treatment for contact urticaria

April 20, 2001

Apligraf marketing application submitted to EMEA

April 19, 2001

Phase III trial begins for Atrix acne therapy

April 19, 2001

Genome of major organism responsible for acne decoded

April 18, 2001

Following first launch, Levulan PDT now under evaluation for Barrett's esophagus

April 11, 2001

Dermik launches new eczema and psoriasis product in Canada

April 11, 2001

Health Canada approves Allergan's Botox for treatment of glabellar lines

April 10, 2001

Milestone payment received by Adolor from GSK for dermal ADL-2-1294

April 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...